• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官捐赠与移植:多方利益相关者的行动呼吁。

Organ donation and transplantation: a multi-stakeholder call to action.

机构信息

Department of Internal Medicine and Paediatrics, Ghent University Hospital, Ghent, Belgium.

European Kidney Health Alliance (EKHA), Brussels, Belgium.

出版信息

Nat Rev Nephrol. 2021 Aug;17(8):554-568. doi: 10.1038/s41581-021-00425-3. Epub 2021 May 5.

DOI:10.1038/s41581-021-00425-3
PMID:33953367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8097678/
Abstract

Although overall donation and transplantation activity is higher in Europe than on other continents, differences between European countries in almost every aspect of transplantation activity (for example, in the number of transplantations, the number of people with a functioning graft, in rates of living versus deceased donation, and in the use of expanded criteria donors) suggest that there is ample room for improvement. Herein we review the policy and clinical measures that should be considered to increase access to transplantation and improve post-transplantation outcomes. This Roadmap, generated by a group of major European stakeholders collaborating within a Thematic Network, presents an outline of the challenges to increasing transplantation rates and proposes 12 key areas along with specific measures that should be considered to promote transplantation. This framework can be adopted by countries and institutions that are interested in advancing transplantation, both within and outside the European Union. Within this framework, a priority ranking of initiatives is suggested that could serve as the basis for a new European Union Action Plan on Organ Donation and Transplantation.

摘要

尽管欧洲的整体捐赠和移植活动高于其他各大洲,但欧洲各国在移植活动的几乎各个方面(例如,移植数量、有功能移植物的人数、活体与死体捐赠率以及扩展标准供者的使用)都存在差异,这表明仍有很大的改进空间。本文中,我们综述了应考虑采取的政策和临床措施,以增加移植机会并改善移植后的结果。该路线图由一个主要的欧洲利益相关者小组在一个专题网络内合作制定,概述了提高移植率所面临的挑战,并提出了 12 个关键领域以及应考虑采取的具体措施,以促进移植。有兴趣在欧盟内外推进移植的国家和机构均可采用该框架。在此框架内,建议对各项举措进行优先级排序,为制定新的欧盟器官捐赠与移植行动计划提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/56276cf022a2/41581_2021_425_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/b1e07b3b68b9/41581_2021_425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/886c168cbccc/41581_2021_425_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/664d85fe825f/41581_2021_425_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/9645340eb548/41581_2021_425_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/56276cf022a2/41581_2021_425_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/b1e07b3b68b9/41581_2021_425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/886c168cbccc/41581_2021_425_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/664d85fe825f/41581_2021_425_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/9645340eb548/41581_2021_425_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/459e/8097678/56276cf022a2/41581_2021_425_Fig5_HTML.jpg

相似文献

1
Organ donation and transplantation: a multi-stakeholder call to action.器官捐赠与移植:多方利益相关者的行动呼吁。
Nat Rev Nephrol. 2021 Aug;17(8):554-568. doi: 10.1038/s41581-021-00425-3. Epub 2021 May 5.
2
Current status of transplantation and organ donation in the Balkans--could it be improved through the South-eastern Europe Health Network (SEEHN) initiative?巴尔干地区的移植和器官捐赠现状——通过东南欧健康网络(SEEHN)倡议能否有所改善?
Nephrol Dial Transplant. 2012 Apr;27(4):1319-23. doi: 10.1093/ndt/gfs071.
3
Deceased donation and organ transplantation in Mexico. Analysis of 12 years and seven strategic proposals.墨西哥的器官捐献与移植。12 年分析和 7 项战略建议。
Cir Cir. 2020;88(3):254-262. doi: 10.24875/CIRU.19001379.
4
Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry.英国的器官捐赠与移植:过去十年——来自英国国家移植登记处的报告。
Transplantation. 2014 Jan 15;97 Suppl 1:S1-S27. doi: 10.1097/01.TP.0000438215.16737.68.
5
Organ donation and transplantation statistics in Belgium for 2012 and 2013.2012年和2013年比利时的器官捐献与移植统计数据。
Transplant Proc. 2014 Nov;46(9):3124-6. doi: 10.1016/j.transproceed.2014.09.170.
6
Donation and transplantation in Latvia--2006.拉脱维亚2006年的捐赠与移植情况
Ann Transplant. 2007;12(1):37-9.
7
[Organ donation in Switzerland].[瑞士的器官捐赠]
Ther Umsch. 2005 Jul;62(7):437-42. doi: 10.1024/0040-5930.62.7.437.
8
The National Transplant Organization donation evolution and transplant activity in Spain.西班牙国家移植组织的捐赠演变及移植活动
Ann Transplant. 1996;1(3):45-56.
9
Does Presumed Consent Save Lives? Evidence from Europe.推定同意能挽救生命吗?来自欧洲的证据。
Health Econ. 2015 Dec;24(12):1560-72. doi: 10.1002/hec.3111. Epub 2014 Oct 2.
10
Present data on organ donation and transplantation in Poland.展示波兰器官捐赠与移植的现有数据。
Transplant Proc. 2009 Oct;41(8):2955-8. doi: 10.1016/j.transproceed.2009.08.008.

引用本文的文献

1
Maximum cold ischemia duration for a kidney allograft: a prediction model for allograft failure at the time of organ allocation.肾移植同种异体移植物的最大冷缺血持续时间:器官分配时移植物失败的预测模型。
EClinicalMedicine. 2025 Jul 5;85:103322. doi: 10.1016/j.eclinm.2025.103322. eCollection 2025 Jul.
2
Health professional and transplant recipient perspectives of kidney transplantation in regional, rural, and remote Australia - a survey study.澳大利亚地区、农村和偏远地区肾脏移植的医疗专业人员及受者观点——一项调查研究
J Nephrol. 2025 Jun;38(5):1403-1412. doi: 10.1007/s40620-025-02331-4. Epub 2025 Jun 16.
3
Assessing health care disparities in US organ procurement organizations.

本文引用的文献

1
Utilization and Outcomes of Single and Dual Kidney Transplants from Older Deceased Donors in the United Kingdom.英国老年尸体供者单肾和双肾移植的利用和结果。
Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1320-1329. doi: 10.2215/CJN.02060220. Epub 2020 Jul 20.
2
Organ transplantation in persons with HIV.艾滋病毒感染者的器官移植。
AIDS. 2020 Jul 1;34(8):1107-1116. doi: 10.1097/QAD.0000000000002518.
3
Knowledge of the Brain Death Concept Among Older People.老年人对脑死亡概念的认知
评估美国器官获取组织中的医疗保健差异。
Sci Rep. 2025 May 19;15(1):17399. doi: 10.1038/s41598-025-01808-3.
4
Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.将白细胞介素-21中和纳米疗法靶向递送至淋巴结和肾脏同种异体移植物可减弱B细胞同种免疫。
Kidney Int. 2025 Jul;108(1):48-56. doi: 10.1016/j.kint.2025.03.017. Epub 2025 Apr 21.
5
Global transplantation: Lessons from organ transplantation organizations worldwide.全球移植:来自全球器官移植组织的经验教训。
World J Transplant. 2025 Mar 18;15(1):99683. doi: 10.5500/wjt.v15.i1.99683.
6
Knowledge, attitudes, and practices of organ, tissue, and cell donation in Nicaragua.尼加拉瓜器官、组织和细胞捐赠的知识、态度及实践情况。
PLOS Glob Public Health. 2025 Mar 18;5(3):e0004329. doi: 10.1371/journal.pgph.0004329. eCollection 2025.
7
Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA).应对欧洲日益高涨的肾脏宣传浪潮:欧洲肾脏健康联盟(EKHA)的开创性作用。
Clin Kidney J. 2025 Jan 9;18(3):sfaf005. doi: 10.1093/ckj/sfaf005. eCollection 2025 Mar.
8
Claudin-2 enhances human antibody-mediated complement-dependent cytotoxicity of porcine endothelial cells by modulating antibody binding and complement activation.Claudin-2通过调节抗体结合和补体激活增强人抗体介导的猪内皮细胞补体依赖性细胞毒性。
Front Immunol. 2025 Feb 18;16:1547512. doi: 10.3389/fimmu.2025.1547512. eCollection 2025.
9
Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells.滤泡调节性T细胞通过抑制同种异体反应性B细胞来抑制小鼠肾移植排斥反应。
Nat Commun. 2025 Mar 4;16(1):2151. doi: 10.1038/s41467-025-57468-4.
10
The evaluation of kidney transplant candidates prior to waitlisting: a scoping review.等待名单前肾移植候选者的评估:一项范围综述
Clin Kidney J. 2024 Nov 22;18(1):sfae377. doi: 10.1093/ckj/sfae377. eCollection 2025 Jan.
Transplant Proc. 2020 Mar;52(2):506-508. doi: 10.1016/j.transproceed.2019.09.019. Epub 2020 Feb 8.
4
Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.性别差异与肾脏替代治疗的启动和维持。
Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1616-1625. doi: 10.2215/CJN.04400419. Epub 2019 Oct 24.
5
Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.自述的高血压事件与活体肾供者和健康非供者的长期肾功能比较。
Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1493-1499. doi: 10.2215/CJN.04020419. Epub 2019 Sep 19.
6
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.国家趋势与 HCV 病毒血症肾脏移植的 1 年结果。
J Am Soc Nephrol. 2019 Oct;30(10):1939-1951. doi: 10.1681/ASN.2019050462. Epub 2019 Sep 12.
7
Association Between Dialysis Facility Ownership and Access to Kidney Transplantation.透析中心所有权与肾移植机会之间的关联。
JAMA. 2019 Sep 10;322(10):957-973. doi: 10.1001/jama.2019.12803.
8
Improving Access to Kidney Transplantation: Business as Usual or New Ways of Doing Business?改善肾移植可及性:照常行事还是采用新的经营方式?
JAMA. 2019 Sep 10;322(10):931-933. doi: 10.1001/jama.2019.12784.
9
Donation after circulatory death today: an updated overview of the European landscape.当今循环性死亡后的器官捐献:欧洲现状的最新概述。
Transpl Int. 2020 Jan;33(1):76-88. doi: 10.1111/tri.13506. Epub 2019 Oct 7.
10
Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.不同肾脏替代治疗方式患者的医疗费用 - 荷兰健康保险索赔数据分析。
PLoS One. 2019 Aug 15;14(8):e0220800. doi: 10.1371/journal.pone.0220800. eCollection 2019.